ÂÜÀòÂÒÂ×

Onur Uzunlar is an experienced finance professional currently serving as the Director of Finance for the Global Rare Business Unit at Alnylam Pharmaceuticals since March 2022, where Onur has also held positions including Director of US Commercial FP&A and Associate Director of Financial Planning and Analysis. Prior experience includes roles at Novartis Oncology as Associate Director of Business Planning & Analytics and Manager of Trade Management BPA, as well as positions in supply chain planning and analysis at Novartis and Sandoz. A strong background in project management is evidenced through significant projects with organizations like the Veterans Health Administration and Harvard Vanguard Medical Associates, focusing on optimizing healthcare delivery and resource allocation. Onur's educational background includes a Master of Science in Healthcare Systems Engineering from Northeastern University and additional degrees in Industrial Engineering from Bilkent University and Gazi University.